Search Results - "SEBTI, Said"

Refine Results
  1. 1

    PTEN counteracts FBXL2 to promote IP3R3- and Ca 2+ -mediated apoptosis limiting tumour growth by Kuchay, Shafi, Giorgi, Carlotta, Simoneschi, Daniele, Pagan, Julia, Missiroli, Sonia, Saraf, Anita, Florens, Laurence, Washburn, Michael P, Collazo-Lorduy, Ana, Castillo-Martin, Mireia, Cordon-Cardo, Carlos, Sebti, Said M, Pinton, Paolo, Pagano, Michele

    Published in Nature (London) (22-06-2017)
    “…In response to environmental cues that promote IP3 (inositol 1,4,5-trisphosphate) generation, IP3 receptors (IP3Rs) located on the endoplasmic reticulum allow…”
    Get full text
    Journal Article
  2. 2

    PTEN counteracts FBXL2 to promote IP3R3- and Ca2+-mediated apoptosis limiting tumour growth by Kuchay, Shafi, Giorgi, Carlotta, Simoneschi, Daniele, Pagan, Julia, Missiroli, Sonia, Saraf, Anita, Florens, Laurence, Washburn, Michael P., Collazo-Lorduy, Ana, Castillo-Martin, Mireia, Cordon-Cardo, Carlos, Sebti, Said M., Pinton, Paolo, Pagano, Michele

    Published in Nature (London) (22-06-2017)
    “…PTEN, a known tumour suppressor, inhibits the FXBL2-dependent degradation of IP3R3, an IP3 receptor, thus augmenting IP3R3-mediated calcium release from the…”
    Get full text
    Journal Article
  3. 3

    The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells by Yang, Hua, Xiang, Shengyan, Kazi, Aslamuzzaman, Sebti, Said M.

    Published in The Journal of biological chemistry (06-03-2020)
    “…In human cancer cells that harbor mutant KRAS and WT p53 (p53), KRAS contributes to the maintenance of low p53 levels. Moreover, KRAS depletion stabilizes and…”
    Get full text
    Journal Article
  4. 4

    Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation by Mahajan, Kiran, Coppola, Domenico, Challa, Sridevi, Fang, Bin, Chen, Y Ann, Zhu, Weiwei, Lopez, Alexis S, Koomen, John, Engelman, Robert W, Rivera, Charlene, Muraoka-Cook, Rebecca S, Cheng, Jin Q, Schönbrunn, Ernst, Sebti, Said M, Earp, H Shelton, Mahajan, Nupam P

    Published in PloS one (19-03-2010)
    “…The AKT/PKB kinase is a key signaling component of one of the most frequently activated pathways in cancer and is a major target of cancer drug development…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Ral GTPase Down-regulation Stabilizes and Reactivates p53 to Inhibit Malignant Transformation by Tecleab, Awet, Zhang, Xiaolei, Sebti, Said M.

    Published in The Journal of biological chemistry (07-11-2014)
    “…Ral GTPases are critical effectors of Ras, yet the molecular mechanism by which they induce malignant transformation is not well understood. In this study, we…”
    Get full text
    Journal Article
  7. 7
  8. 8

    δ-Tocotrienol, a natural form of vitamin E, inhibits pancreatic cancer stem-like cells and prevents pancreatic cancer metastasis by Husain, Kazim, Centeno, Barbara A, Coppola, Domenico, Trevino, Jose, Sebti, Said M, Malafa, Mokenge P

    Published in Oncotarget (09-05-2017)
    “…The growth, metastasis, and chemotherapy resistance of pancreatic ductal adenocarcinoma (PDAC) is characterized by the activation and growth of…”
    Get full text
    Journal Article
  9. 9

    MDMX Overexpression Prevents p53 Activation by the MDM2 Inhibitor Nutlin by Hu, Baoli, Gilkes, Daniele M., Farooqi, Bilal, Sebti, Said M., Chen, Jiandong

    Published in The Journal of biological chemistry (03-11-2006)
    “…The p53 tumor suppressor plays a key role in maintaining genomic stability and protection against malignant transformation. MDM2 and MDMX are both p53-binding…”
    Get full text
    Journal Article
  10. 10

    Combined HMG-COA reductase and prenylation inhibition in treatment of CCM by Nishimura, Sayoko, Mishra-Gorur, Ketu, Park, JinSeok, Surovtseva, Yulia V., Sebti, Said M., Levchenko, Andre, Louvi, Angeliki, Gunel, Murat

    “…Cerebral cavernous malformations (CCMs) are common vascular anomalies that develop in the central nervous system and, more rarely, the retina. The lesions can…”
    Get full text
    Journal Article
  11. 11

    Vitamin E δ-tocotrienol augments the antitumor activity of gemcitabine and suppresses constitutive NF-κB activation in pancreatic cancer by Husain, Kazim, Francois, Rony A, Yamauchi, Teruo, Perez, Marta, Sebti, Said M, Malafa, Mokenge P

    Published in Molecular cancer therapeutics (01-12-2011)
    “…The NF-κB transcription factor functions as a crucial regulator of cell survival and chemoresistance in pancreatic cancer. Recent studies suggest that…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Structure-based Design of High Affinity Peptides Inhibiting the Interaction of p53 with MDM2 and MDMX by Phan, Jason, Li, Zhenyu, Kasprzak, Agnieszka, Li, Baozong, Sebti, Said, Guida, Wayne, Schönbrunn, Ernst, Chen, Jiandong

    Published in The Journal of biological chemistry (15-01-2010)
    “…MDM2 and MDMX function as key regulators of p53 by binding to its N terminus, inhibiting its transcriptional activity, and promoting degradation. MDM2 and MDMX…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Identification of novel inhibitors that disrupt STAT3-DNA interaction from a γ-AApeptide OBOC combinatorial library by Teng, Peng, Zhang, Xiaolei, Wu, Haifan, Qiao, Qiao, Sebti, Said M, Cai, Jianfeng

    “…From a γ-AApeptide-based one-bead-one-compound (OBOC) combinatorial library, we identified γ-AApeptides that can selectively inhibit STAT3-DNA interaction and…”
    Get more information
    Journal Article
  20. 20